| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SELENOT VMP1 ACSL4 PIGT SCAP CYP4A11 MTOR CYP4B1 TEX2 LPCAT3 CERS3 MMP27 RNF43 RYR1 | 2.39e-04 | 1293 | 77 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SELENOT VMP1 ACSL4 PIGT SCAP CYP4A11 MTOR CYP4B1 TEX2 LPCAT3 CERS3 MMP27 RNF43 RYR1 | 2.51e-04 | 1299 | 77 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SELENOT VMP1 ACSL4 PIGT SCAP CYP4A11 MTOR CYP4B1 TEX2 LPCAT3 CERS3 MMP27 RNF43 RYR1 | 3.12e-04 | 1327 | 77 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | TORC2 complex | 4.74e-04 | 9 | 77 | 2 | GO:0031932 | |
| GeneOntologyCellularComponent | TOR complex | 8.63e-04 | 12 | 77 | 2 | GO:0038201 | |
| Domain | MABP | 9.24e-05 | 4 | 74 | 2 | IPR023341 | |
| Domain | MABP | 9.24e-05 | 4 | 74 | 2 | PS51498 | |
| Domain | - | 1.54e-04 | 5 | 74 | 2 | 2.120.10.10 | |
| Domain | PPR | 4.27e-04 | 8 | 74 | 2 | PS51375 | |
| Domain | Sialidases | 5.48e-04 | 9 | 74 | 2 | IPR011040 | |
| Domain | TF_fork_head_CS_2 | 8.02e-04 | 46 | 74 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 8.54e-04 | 47 | 74 | 3 | IPR018122 | |
| Domain | FH | 9.65e-04 | 49 | 74 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 9.65e-04 | 49 | 74 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 9.65e-04 | 49 | 74 | 3 | PS00658 | |
| Domain | Fork_head_dom | 9.65e-04 | 49 | 74 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 9.65e-04 | 49 | 74 | 3 | PS50039 | |
| Domain | Forkhead | 9.65e-04 | 49 | 74 | 3 | PF00250 | |
| Domain | uDENN | 1.37e-03 | 14 | 74 | 2 | SM00800 | |
| Domain | uDENN | 1.57e-03 | 15 | 74 | 2 | PF03456 | |
| Domain | HEAT | 1.58e-03 | 58 | 74 | 3 | IPR000357 | |
| Domain | UDENN | 1.79e-03 | 16 | 74 | 2 | PS50946 | |
| Domain | DDENN | 1.79e-03 | 16 | 74 | 2 | PS50947 | |
| Domain | DENN | 1.79e-03 | 16 | 74 | 2 | SM00799 | |
| Domain | dDENN | 1.79e-03 | 16 | 74 | 2 | SM00801 | |
| Domain | DENN | 1.79e-03 | 16 | 74 | 2 | PF02141 | |
| Domain | dDENN_dom | 1.79e-03 | 16 | 74 | 2 | IPR005112 | |
| Domain | uDENN_dom | 1.79e-03 | 16 | 74 | 2 | IPR005113 | |
| Domain | dDENN | 1.79e-03 | 16 | 74 | 2 | PF03455 | |
| Domain | DENN | 1.79e-03 | 16 | 74 | 2 | PS50211 | |
| Domain | DENN_dom | 1.79e-03 | 16 | 74 | 2 | IPR001194 | |
| Domain | - | 1.88e-03 | 222 | 74 | 5 | 1.25.10.10 | |
| Domain | HEAT_REPEAT | 2.70e-03 | 70 | 74 | 3 | PS50077 | |
| Domain | Pentatricopeptide_repeat | 3.71e-03 | 23 | 74 | 2 | IPR002885 | |
| Domain | ARM-like | 4.35e-03 | 270 | 74 | 5 | IPR011989 | |
| Domain | - | 5.30e-03 | 283 | 74 | 5 | 1.10.10.60 | |
| Domain | AMP-binding | 6.27e-03 | 30 | 74 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 6.27e-03 | 30 | 74 | 2 | IPR000873 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PIK3R4 ACSL4 NCOR2 NEU2 SCAP GAL3ST1 CYP4A11 CYP4B1 LPCAT3 CERS3 TNFAIP8L1 | 3.17e-05 | 620 | 57 | 11 | MM15193 |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PIK3R4 ACSL4 NCOR2 NEU2 SCAP GAL3ST1 CYP4A11 CYP4B1 LPCAT3 CD36 CERS3 TNFAIP8L1 | 3.99e-05 | 757 | 57 | 12 | M27451 |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 9.14e-05 | 22 | 57 | 3 | M13897 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 1.05e-04 | 23 | 57 | 3 | MM14993 | |
| Pathway | WP_PPAR_SIGNALING | 1.52e-04 | 67 | 57 | 4 | M39553 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 1.53e-04 | 26 | 57 | 3 | M27558 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 1.71e-04 | 69 | 57 | 4 | M13088 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.71e-04 | 27 | 57 | 3 | M27422 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 2.12e-04 | 73 | 57 | 4 | MM15995 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.35e-04 | 30 | 57 | 3 | MM15170 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 3.14e-04 | 33 | 57 | 3 | M11725 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 3.43e-04 | 34 | 57 | 3 | MM14992 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 3.74e-04 | 35 | 57 | 3 | M249 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 4.07e-04 | 36 | 57 | 3 | MM15339 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 4.42e-04 | 37 | 57 | 3 | M27641 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 5.99e-04 | 41 | 57 | 3 | MM14505 | |
| Pathway | PID_CXCR3_PATHWAY | 6.90e-04 | 43 | 57 | 3 | M222 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 8.63e-04 | 11 | 57 | 2 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 8.63e-04 | 11 | 57 | 2 | MM15035 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 8.96e-04 | 47 | 57 | 3 | MM14885 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 9.53e-04 | 48 | 57 | 3 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 9.53e-04 | 48 | 57 | 3 | MM15441 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 1.01e-03 | 110 | 57 | 4 | M27162 | |
| Pathway | REACTOME_EICOSANOIDS | 1.03e-03 | 12 | 57 | 2 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.03e-03 | 12 | 57 | 2 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 1.03e-03 | 12 | 57 | 2 | MM14845 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 1.20e-03 | 52 | 57 | 3 | M7561 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.34e-03 | 54 | 57 | 3 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.34e-03 | 54 | 57 | 3 | M620 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.63e-03 | 15 | 57 | 2 | M27126 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.63e-03 | 15 | 57 | 2 | M47663 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 1.63e-03 | 15 | 57 | 2 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1 | 1.86e-03 | 16 | 57 | 2 | M47457 | |
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 2.08e-07 | 6 | 77 | 3 | 27092474 | |
| Pubmed | Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis. | 2.08e-07 | 6 | 77 | 3 | 28784627 | |
| Pubmed | Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. | 3.63e-07 | 7 | 77 | 3 | 15718470 | |
| Pubmed | Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. | 5.06e-07 | 29 | 77 | 4 | 26633882 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 5.80e-07 | 8 | 77 | 3 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 8.68e-07 | 9 | 77 | 3 | 12412011 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOR2 SCAP CELSR2 MTOR BICRA RBM19 FBRS LRP4 BABAM2 RNF43 RYR1 TBCD ZNF503 | 8.75e-07 | 1105 | 77 | 13 | 35748872 |
| Pubmed | 1.43e-06 | 250 | 77 | 7 | 18660489 | ||
| Pubmed | 1.70e-06 | 11 | 77 | 3 | 33052068 | ||
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 2.94e-06 | 13 | 77 | 3 | 16884697 | |
| Pubmed | 2.94e-06 | 13 | 77 | 3 | 7957066 | ||
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 4.66e-06 | 15 | 77 | 3 | 7689224 | |
| Pubmed | 4.66e-06 | 15 | 77 | 3 | 22045912 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18831768 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20501647 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32588529 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26536660 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20332342 | ||
| Pubmed | mTORC2 sustains thermogenesis via Akt-induced glucose uptake and glycolysis in brown adipose tissue. | 4.84e-06 | 2 | 77 | 2 | 26772600 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34541875 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28123351 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25893736 | ||
| Pubmed | Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells. | 4.84e-06 | 2 | 77 | 2 | 19341427 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20620941 | ||
| Pubmed | Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. | 4.84e-06 | 2 | 77 | 2 | 20226010 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25740823 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29099279 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24270265 | ||
| Pubmed | mTOR complex 2 in adipose tissue negatively controls whole-body growth. | 4.84e-06 | 2 | 77 | 2 | 19497867 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21376236 | ||
| Pubmed | Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. | 4.84e-06 | 2 | 77 | 2 | 26170313 | |
| Pubmed | Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. | 4.84e-06 | 2 | 77 | 2 | 22473959 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 38073444 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25564616 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 5.72e-06 | 16 | 77 | 3 | 8861101 | |
| Pubmed | 5.72e-06 | 16 | 77 | 3 | 10208738 | ||
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 9.86e-06 | 19 | 77 | 3 | 9895322 | |
| Pubmed | 1.16e-05 | 20 | 77 | 3 | 12812790 | ||
| Pubmed | 1.35e-05 | 21 | 77 | 3 | 9449667 | ||
| Pubmed | PDK1 plays a vital role on hematopoietic stem cell function. | 1.45e-05 | 3 | 77 | 2 | 28694518 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 23440873 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 12906859 | ||
| Pubmed | Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. | 1.45e-05 | 3 | 77 | 2 | 21170086 | |
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 1.45e-05 | 3 | 77 | 2 | 25385646 | |
| Pubmed | Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. | 1.45e-05 | 3 | 77 | 2 | 25059582 | |
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 1.45e-05 | 3 | 77 | 2 | 23898069 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 28813526 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 34455055 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 1.45e-05 | 3 | 77 | 2 | 19724909 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 21358638 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 1.45e-05 | 3 | 77 | 2 | 20008564 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 35982899 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 26926384 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 18614546 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 27690224 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 23049074 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 27016480 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 28128208 | ||
| Pubmed | Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. | 1.45e-05 | 3 | 77 | 2 | 22285861 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 20338997 | ||
| Pubmed | Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. | 1.45e-05 | 3 | 77 | 2 | 26598511 | |
| Pubmed | mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. | 1.45e-05 | 3 | 77 | 2 | 20978191 | |
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 1.45e-05 | 3 | 77 | 2 | 23212520 | |
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 1.45e-05 | 3 | 77 | 2 | 24958889 | |
| Pubmed | TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. | 1.45e-05 | 3 | 77 | 2 | 33416177 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 29328491 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 19145465 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 34331380 | ||
| Pubmed | ER phospholipid composition modulates lipogenesis during feeding and in obesity. | 1.45e-05 | 3 | 77 | 2 | 28846071 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 31668132 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 9271096 | ||
| Pubmed | 1.56e-05 | 22 | 77 | 3 | 17389379 | ||
| Pubmed | 1.61e-05 | 504 | 77 | 8 | 34432599 | ||
| Pubmed | Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. | 2.04e-05 | 24 | 77 | 3 | 11820816 | |
| Pubmed | 2.04e-05 | 24 | 77 | 3 | 29992973 | ||
| Pubmed | Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. | 2.62e-05 | 26 | 77 | 3 | 15857913 | |
| Pubmed | Post-translational modifications regulate distinct functions of CARMA1 and BCL10. | 2.89e-05 | 4 | 77 | 2 | 17468049 | |
| Pubmed | RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4. | 2.89e-05 | 4 | 77 | 2 | 38040804 | |
| Pubmed | mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. | 2.89e-05 | 4 | 77 | 2 | 16919458 | |
| Pubmed | Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. | 2.89e-05 | 4 | 77 | 2 | 18504440 | |
| Pubmed | Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains. | 2.89e-05 | 4 | 77 | 2 | 23762398 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 28475179 | ||
| Pubmed | mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice. | 2.89e-05 | 4 | 77 | 2 | 26631481 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 22550181 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 31387191 | ||
| Pubmed | Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities. | 2.89e-05 | 4 | 77 | 2 | 19619545 | |
| Pubmed | mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. | 2.89e-05 | 4 | 77 | 2 | 16221682 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24006489 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 26645692 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 25887293 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 24662050 | ||
| Pubmed | Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. | 2.89e-05 | 4 | 77 | 2 | 16603397 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 31636454 | ||
| Pubmed | Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway. | 2.89e-05 | 4 | 77 | 2 | 20438709 | |
| Pubmed | Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. | 2.89e-05 | 4 | 77 | 2 | 23429704 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 36411371 | ||
| Pubmed | Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. | 2.89e-05 | 4 | 77 | 2 | 21606591 | |
| Pubmed | CMPK1 and RBP3 are associated with corneal curvature in Asian populations. | 2.89e-05 | 4 | 77 | 2 | 24963161 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 22399812 | ||
| Cytoband | 9q21.11 | 1.78e-05 | 30 | 77 | 3 | 9q21.11 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 6.03e-05 | 5 | 45 | 2 | 1333 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.75e-03 | 25 | 45 | 2 | 504 | |
| GeneFamily | Cytochrome P450 family 4 | 3.62e-03 | 36 | 45 | 2 | 1003 | |
| GeneFamily | WD repeat domain containing | 4.03e-03 | 262 | 45 | 4 | 362 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 2.40e-05 | 198 | 77 | 5 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.46e-05 | 199 | 77 | 5 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| Disease | urate measurement | TMEM11 VMP1 ANKRD33 SLC52A1 WDR20 MACROD1 PKHD1 LRP4 BABAM2 KLB | 6.13e-05 | 895 | 72 | 10 | EFO_0004531 |
| Disease | 10-undecenoate 11:1n1 measurement | 1.22e-04 | 7 | 72 | 2 | EFO_0021099 | |
| Disease | X-18899 measurement | 1.22e-04 | 7 | 72 | 2 | EFO_0800793 | |
| Disease | X-24748 measurement | 1.63e-04 | 8 | 72 | 2 | EFO_0022136 | |
| Disease | pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement | 1.63e-04 | 8 | 72 | 2 | EFO_0800494 | |
| Disease | anemia (phenotype) | 1.63e-04 | 8 | 72 | 2 | EFO_0004272 | |
| Disease | intraocular pressure measurement | 2.44e-04 | 509 | 72 | 7 | EFO_0004695 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.18e-04 | 11 | 72 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | undecenoylcarnitine (C11:1) measurement | 4.50e-04 | 13 | 72 | 2 | EFO_0800588 | |
| Disease | Malformations of Cortical Development | 5.24e-04 | 14 | 72 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 5.24e-04 | 14 | 72 | 2 | C0431380 | |
| Disease | myocardial infarction (implicated_via_orthology) | 5.71e-04 | 66 | 72 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.89e-04 | 16 | 72 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.34e-03 | 195 | 72 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.50e-03 | 507 | 72 | 6 | C2239176 | |
| Disease | osteoarthritis (is_implicated_in) | 2.13e-03 | 28 | 72 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.13e-03 | 28 | 72 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Child Development Disorders, Specific | 2.28e-03 | 29 | 72 | 2 | C0085997 | |
| Disease | Child Development Deviations | 2.28e-03 | 29 | 72 | 2 | C0085996 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPYLLIYPQLHLVRT | 1141 | Q68DN1 | |
| PKDTYIGYLPLAHVL | 311 | O60488 | |
| HYNALYGLGLLLTPP | 46 | Q86XJ0 | |
| LTPAFHYDILKPYVG | 146 | Q02928 | |
| PLHLAIAYGCYPVLS | 171 | A6NGH8 | |
| IYRTLAGLLPHNYDP | 2251 | Q9HCU4 | |
| ALAVYIHPYPNNILS | 1411 | Q6DHV5 | |
| ASPNLSYSRPYGHLL | 41 | Q92988 | |
| FLYRYSISGPHVLPI | 331 | Q7Z401 | |
| LFSKYGPLSELHYPI | 421 | Q9Y4C8 | |
| GHVPLVSLLLNYYVG | 176 | Q7Z3H0 | |
| GAHLLSVSLYYGPLL | 241 | P0DN80 | |
| ADALHTLRNYLPPVY | 141 | A6NI15 | |
| IRGYAVLPDYPKSIH | 351 | Q9H306 | |
| IPLDAAAAYYLPRHL | 1641 | Q9Y618 | |
| HPSLSYEPALLQPYL | 196 | Q16849 | |
| YPYVGILHVRDSLIP | 436 | Q8NC56 | |
| ELLQALPDYSLGPHY | 506 | Q96S65 | |
| HPLRYLLLSAPVYAG | 266 | Q6VB84 | |
| GVVLPTPLLLRHYHY | 156 | Q8NGJ5 | |
| QLPLGFLYVHHTYVP | 401 | Q96PD5 | |
| HLAFLSGLPALYYVA | 781 | Q6ZU69 | |
| HLAFLSGLPALYYVA | 511 | Q63HN1 | |
| PPSYIYGAQHLLRLF | 446 | Q8N5Y2 | |
| LLYPPGIELIAAFYG | 1051 | Q9P265 | |
| LGLPVDIPHYTRLYS | 296 | Q8N7G0 | |
| LGLFYLVGYTLLSPH | 236 | Q6P1A2 | |
| LYFVVSYLPSLPHPA | 481 | P49279 | |
| LPFLYVLLPAVYSGI | 41 | P48146 | |
| LQRPHVYLPIHLYGQ | 871 | Q6R327 | |
| YTGHRVPSFQLILYP | 121 | A6NFQ7 | |
| LISLHIAGNPTYYVP | 56 | P78509 | |
| APRLYYPLLLEHTLG | 261 | P0CG20 | |
| GAHAYRIPALLYLPG | 16 | Q9Y3R4 | |
| LLLVYSYAVPPLHAG | 26 | Q99999 | |
| PSHLYVTIPYAFLLL | 36 | Q8IU89 | |
| YGLEPAHPLLYSRLA | 396 | Q9HAH7 | |
| YPKLYLSPRIEHALG | 216 | Q9NXR7 | |
| CNLLTLYPYGDPHVI | 991 | A6NNT2 | |
| GRPVYISLPHFLYAS | 336 | P16671 | |
| YRLPAKYVIHTVGPI | 216 | Q9BQ69 | |
| FLYRYSVSGPHRLPL | 336 | O75064 | |
| LYYPTHAHLGLPEPL | 641 | Q86Z14 | |
| LTPGFHYDVLKPYVA | 141 | P13584 | |
| LHRLLPYHVYQGALP | 1111 | Q9NZM4 | |
| PVEILPFLYLGSAYH | 196 | Q13115 | |
| YHAALPMLIYGSLPI | 476 | Q9Y226 | |
| YNHGLLCASYPIPII | 16 | Q12770 | |
| HLPGPLRAGYYDLLI | 1701 | P21817 | |
| HLVYYPSARPVLSLS | 991 | Q8IZU8 | |
| GYNARAPLHYLAPLL | 166 | Q9BTY7 | |
| LTDIGRYHPQALIYP | 1961 | P42345 | |
| GIRNLIFYELPTYPH | 681 | Q68CQ4 | |
| YLPQPIYRHIASFLS | 76 | P62341 | |
| HLIYDLDVAPYIGLP | 256 | Q96Q11 | |
| YALLAGLPPVFGLYS | 111 | Q9BXS9 | |
| LLLTEGPHLYYVDPV | 476 | O15530 | |
| HPLRYLLLSAPVYAG | 266 | Q5VV16 | |
| HPLRYLLLSAPVYAG | 266 | Q3SYB3 | |
| YHLPAAYLLGPSRSA | 351 | Q68DV7 | |
| LGFYPSITHRTIPYL | 526 | P03915 | |
| EGLYKLLPHSEYSRP | 21 | Q8TBZ3 | |
| RDLAPGPHYLSVFYT | 1541 | P08F94 | |
| PHRVYTPLALGLGLY | 926 | E7EW31 | |
| INIYPEYILPGIAHL | 456 | Q99570 | |
| AAQYYVAGHLPVKLP | 246 | Q8N5D0 | |
| PLALPLDYSHYISLP | 96 | P17152 | |
| PYIISYLHPGNTILH | 181 | P10745 | |
| LLYNTHPYRAFPVLL | 371 | Q969N2 | |
| LPYGRLAYHLAVVLG | 306 | Q9NWF4 | |
| PTIPYHKLADLRYLS | 11 | O43353 | |
| VPGLDPAHRYKLLLY | 1831 | P22105 | |
| QLYLLGSYNALPPLH | 691 | Q8IYQ7 | |
| ALKSGYPLVYPTHPL | 461 | Q96F45 | |
| QLLGLPTYRYHVLLG | 971 | Q9BTW9 | |
| YLILPLPHYVSGLFL | 486 | Q8IWB9 | |
| LAALYGPAEPYRSHL | 156 | Q8WVP5 | |
| PFLLHAFYPGYPLLL | 186 | Q8IZ20 | |
| HYQPLLLLYADPQGT | 341 | Q70EL1 | |
| LYLGPHIASVTLAAY | 136 | Q96GC9 | |
| PVQHPYGLTLLDSYI | 1251 | O75096 |